logo

Last Update

This profile was last updated on 12/20/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Crystal Rice?

Crystal Rice

Spokeswoman

Food and Drug Administration

HQ Phone:  (301) 827-6500

Direct Phone: (301) ***-****direct phone

Email: r***@***.gov

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Food and Drug Administration

5600 Fishers Lane

Rockville, Maryland,20852

United States

Company Description

China's Food and Drug Administration (SFDA) is now offering a reward of about 50,000 US dollars for relevant information on counterfeit drug production. The bounty aims to "encourage the public to report illegal activities so as to determine, control and elimi...more

Web References(141 Total References)


The Center for Medicine in the Public Interest | REMS safety summit: Risk management gets its third checkup

www.cmpi.org [cached]

FDA representative Crystal Rice said that pharmacists could help communicate with physicians who are new to REMS and "help them complete the needed processes for a particular product," but that pharmacists should not be expected "to be the primary source of information regarding the correct prescribing choice for a physician's patients."
FDA is planning a number of projects to help pharmacists, Rice said, including a uniform REMS interface for prescribers, expanded pharmacy access to REMS, CE for pharmacists, and more. "We are researching the possibilities presented by today's technology for using current or developing electronic systems to implement the registration and prescribing requirements of REMS," Rice said. FDA is also "very involved in ongoing education for pharmacists and other stakeholders," Rice said, "to decrease the burden of the REMS process."


Vioxx News - Claimshelp.com - Advocates for the Insured

claimshelp.com [cached]

FDA spokeswoman Crystal Rice says the agency will continue to monitor drugs in the same class as Vioxx.
Besides Merck's Arcoxia, the FDA is considering whether to approve Novartis' Prexige. Pfizer is expected to resubmit an application for parecoxib by year's end. The FDA turned down its original application in 2001 for lack of data. Since becoming aware of the Vioxx study's finding, Rice says, the FDA is "much more sensitized to the possibility of seeing this adverse event" in related drugs.


pro.psychcentral.com

According to FDA spokeswoman Crystal Rice, six of HC's deaths were in adults, which the FDA omitted from its analysis because of the high baseline rate of SUDs in adults.


vioxxlawyer.org

However, according to FDA' spokesperson, Crystal Rice, no drug is ever created to be fully safe for administration among patients.
Also according to her, all drugs have side effects and there is no way that the FDA can wait for several years before it approves a certain medication especially if it is created as an immediate cure. Rest assure though, according to spokesperson Rice, they would become more careful in weighing the pros and cons of every treatment bearing in mind the repercussion of their actions and bearing in mind that at all times, it is the safety of their patients that is most important.


Vioxx Lawyer - Vioxx Recall Injury Attorney - Vioxx Recall Incites Concerns with FDA

www.vioxxfirms.com [cached]

In response to reports of thousands of injuries related to Vioxx, FDA spokeswoman, Crystal Rice, advised that "No drug is fully safe," and stated that the FDA acted appropriately "based on the risk-benefit profile for a drug and the societal need and desire for new drugs".


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory